Delivery Order SPE2DB20D3303-SPE2DB24FY3C3

Award Date 11/15/23
Potential Completion Date 11/16/23
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562655056 - Lidocaine 2% Viscous Solution, 100 ML, with a ceiling value of $1,994.40 and a performance period through November 1, 2023. This is a firm fixed price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,692.34, is for the delivery of 100ML bottles of 2% lidocaine viscous solution. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of January 22, 2025 and was awarded on January 21, 2025. This contract is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,070.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567130613 - Lidocaine 2% Viscous Solution 100ML, a medical product used in various healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 4, 2025. It is not designated as a...
This federal contract award, valued at $11,154.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 2% Viscous Solution in 100ml bottles. It is a Firm Fixed Price Delivery Order contract with a completion date of December 14, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 100ml bottles of 2% lidocaine viscous solution, with a potential value of $1,335.63 and a completion date of March 4, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,564,313,846 units of Lidocaine 2% Viscous 15 ML Cup. The contract has a firm-fixed price of $1,175.73 and a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation. The award is for $1,186.34 to supply 100mL bottles of 2% Lidocaine Viscous solution. The contract has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. This order is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Lidocaine 2% Viscous Solution, 100 ML. The contract has a ceiling value of $2,594.03 and a period of performance through December 18, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award is for the delivery of Lidocaine 2% Viscous 15 ML cups to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, the prime contractor. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $8,353.39 and an ultimate completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FY3C3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 2% Viscous Solution in 100ml bottles. The contract has a ceiling value of $9,165.50 and a completion date of November 16, 2023. This is not a set-aside contract.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/12/25, 10:05 AM